Hydromorphone HCl prolonged-release tablets (BID, twice daily), (4 mg, 8 mg, 16 mg, 24 mg)
Develco Pharma GmbH
Country
City
Schopfheim
Address
Grienmatt 27, 79650
Develco Pharma has been engaged in the production and development of medications containing non-brand name active components since 2006. Our proficient team actively explores creative methods for formulating drugs, designing and executing clinical trials, preparing regulatory paperwork, and manufacturing, examining, and packaging intricate dosage forms. Our specialization lies in the delayed or altered release of active ingredients in order to enhance the benefits for patients.